Uncovering the Truth: Kaplan Fox Kilsheimer LLP Launches Investigation into Eagle Pharmaceuticals Inc. (NASDAQ: EGRX)
Kaplan Fox & Kilsheimer LLP Investigates Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) The Investigation NEW YORK, Nov. 29, 2023 (GLOBE NEWSWIRE) — Kaplan Fox & Kilsheimer LLP is investigating potential claims on behalf of investors who purchased securities of Woodcliff Lake, New Jersey-based Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”). If you purchased Eagle…